Floatz logo

2-HYDROXYOLEIC ACID (SODIUM SALT)

Neoplasm

Laminar PharmaceuticalsSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

928 Active assets in the Neoplasm cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
Astellas Pharma Inc
Phase 2BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
Sanofi
Phase 4BB
VITAMIN D
Tanta University
Phase 4BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
Bxcl501
Medical College of Wisconsin
Phase 4BB

View all 50 →

Same molecule, other indications

2-HYDROXYOLEIC ACID (SODIUM SALT) is also rated in:

glioblastomaDormant
B
Indicative ·
60 / 100
View asset →
Solid Tumor, Unspecified, ChildDormant
CCC
Indicative ·
48 / 100
View asset →
malignant gliomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →